Pediatr Nephrol
Pediatric Nephrology (Berlin, Germany)
0931-041X
1432-198X
Springer-Verlag
Berlin/Heidelberg


2335288
18414901
785
10.1007/s00467-008-0785-2
Educational Review


Chronic kidney disease after liver, cardiac, lung, heart–lung, and hematopoietic stem cell transplant

Hingorani
Sangeeta

sangeeta.hingorani@seattlechildrens.org



Pediatrics–University of Washington, 4800 Sandpoint Way NE M1–5, Seattle, WA 98015 USA 

15
4
2008

6
2008

23
6
879
888
15
8
2007

30
1
2008

31
1
2008


© IPNA 2008

Patient survival after cardiac, liver, and hematopoietic stem cell transplant (HSCT) is improving; however, this survival is limited by substantial pretransplant and treatment-related toxicities. A major cause of morbidity and mortality after transplant is chronic kidney disease (CKD). Although the majority of CKD after transplant is attributed to the use of calcineurin inhibitors, various other conditions such as thrombotic microangiopathy, nephrotic syndrome, and focal segmental glomerulosclerosis have been described. Though the immunosuppression used for each of the transplant types, cardiac, liver and HSCT is similar, the risk factors for developing CKD and the CKD severity described in patients after transplant vary. As the indications for transplant and the long-term survival improves for these children, so will the burden of CKD. Nephrologists should be involved early in the pretransplant workup of these patients. Transplant physicians and nephrologists will need to work together to identify those patients at risk of developing CKD early to prevent its development and progression to end-stage renal disease.

Keywords
Chronic kidney disease
Liver transplant
Cardiac transplant
Hematopoietic stem cell transplant
Calcineurin inhibitors
Risk factors
Epidemiology
Lung transplant

issue-copyright-statement
© IPNA 2008




Introduction
1
1
19
Table 1
Percentage of patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) based on transplant type

Transplant type
CKD
ESRD
Reference


Liver
28–86%
0–8%
1
5
]

Cardiac
7–54%
2%
6
10
]

Heart–lung
34%
7–16%
11
13
]

Hematopoietic stem cell transplantation
18–42%
5–8%
14
19
]





This review focuses on the epidemiology, risk factors, and outcomes of children who develop CKD after liver, cardiac, lung, heart–lung, and stem cell transplant.
Liver transplant
Epidemiology
20
2
1
2
2
2
3
2
4
4
Table 2
National Kidney Foundation Kidney Disease Outcomes Quality Initiative definition of chronic kidney disease by stage

Stage
Description
2
)


1
Kidney damage with normal or ↑ GFR
≥ 90

2
Kidney damage with mild ↓ GFR
60–89

3
Moderate ↓ GFR
30–59

4
Severe ↓ GFR
15–29

5
Kidney failure
<15 or dialysis



eGFR
 estimated glomerular filtration rate





Risk factors for developing CKD
21
22
3
23
24
Table 3
Liver diseases associated with preexisting renal disease

Tyrosinemia

Autosomal recessive polycystic kidney disease

Alagille’s syndrome

Primary hyperoxaluria

Hepatitis B- and C-related glomerulonephritis





4
2
1
20
25
26
Table 4
Risk factors for developing chronic kidney disease by type of transplant

Risk factor common to all transplant types


Calcineurin inhibitor use

Liver


2
 at 1 year after transplant

Pretransplant renal dysfunction

Acute renal failure

Preexisting diabetes

Age

Female gender

Hepatitis C

Cardiac


Pretransplant dialysis

Hypertrophic cardiomyopathy

African American race

Previous transplant

Pretransplant diabetes

Extracorporeal membrane oxygenation use

Heart–lung


Hypertension posttransplant

Elevated serum creatinine at 1 month posttransplant

Hematopoietic stem cell transplant


Acute graft-versus-host disease grades II–IV

Older age

Transplant from an unrelated donor

Acute renal failure

Chronic graft vs. host disease

Total body irradiation






Calcineurin inhibitors
27
25
28
29
30
31
].
32
33
33
34
]. These studies suggest that decreasing calcineurin inhibitor exposure by adding MMF or eliminating long-term exposure by switching to sirolimus can have beneficial effects on renal function in children after liver transplantation.


Cardiac transplantation
Epidemiology
7
6
7
10
7
10
9
35
36
].

Risk factors for development of CKD after cardiac transplant
37
37
12
35
36
38
39
13
40
].

Calcineurin inhibitors
41
2
42
43
2
2
2
44
45
].


Heart–lung and lung transplantation
Epidemiology
11
11
13
12
].

Risk factors for CKD after heart–lung and lung transplant
11
12
13
].


Hematopoietic stem cell transplant
Epidemiology
15
17
14
46
]. Therefore, baseline assessments not only of serum creatinine but also urinalyses and more formal estimations of GFR are warranted. Accurate assessment of baseline renal function can help guide later medication dosing.
47
]).

Histopathology of TMA after HSCT
Microscopic examination of kidney biopsy specimens from patients with TMA-associated CKD demonstrates mesangiolysis and loss of endothelial cells with expansion of the subendothelium and occlusion of capillary loops. On electron micrographs, there is extensive widening of the space between the glomerular basement membrane and the subendothelium, with amorphous deposits that are not immune complexes.

Risk factors for HUS after HSCT
14
15
48
49
15
27
50
54
55
56
17
57
59
14
48
]. All seven children had leukemia, and all received cyclophosphamide alone or with cytosine arabinoside and vepeside, in addition to single-dose TBI as part of their conditioning regimen. Three patients developed CKD without hypertension, and four developed HUS with severe hypertension and microangiopathic hemolytic anemia. Of these, two of the four had normalization of their renal function. Follow-up biopsies, however, showed extensive scarring of the renal parenchyma but almost complete resolution of the mesangiolysis. The glomeruli were globally sclerotic, ischemic, or demonstrated mesangial hypercellularity. Thus, there was evidence of persistent and progressive renal damage in these patients despite normalization of serum creatinine and urinalysis. The occurrence of two different clinical presentations, CKD without hypertension and HUS with hypertension, but similar pathology in these children supports the notion that this is a spectrum of disease rather than distinct pathophysiologic processes.

GVHD-related CKD
60
63
2
63
64
65
66
N
67
].

Risk factors for GVHD-related CKD
68
2
62
60
61
69
60
17
]. In this study, TBI was not associated with development of CKD.

Nephrotic syndrome (NS) after HSCT
70
70
71
71
72
76
77
].


Management of CKD after liver, cardiac, lung, and HSCT
18
26
78
79
83
84
85
]. Urinalyses including a microalbumin to creatinine ratio should also be part of the pretransplant workup, and urinalyses should be monitored closely following transplant.
86
87
90
91
92
].
93
94
78
1
Fig. 1
Bold numbers
102
]




95
96
]. However, prior to changes in immunosuppression, a kidney biopsy may be indicated to define the etiology of the kidney injury and better tailor therapy to prevent or slow disease progression.
19
97
101
].
Questions

Calcineurin inhibitors

Total body irradiation

Acute renal failure

Hypertension




Nephrotic syndrome

Acute glomerulonephritis

Thrombotic microangiopathy

GVHD-related CKD




Preexisting renal disease

Race

Pretransplant diabetes

All of the above




Reducing exposure to calcineurin inhibitors

ACEI and/or ARB

Calcium-channel blockers

Statin use




Graft-versus-host disease

Total body irradiation

Calcineurin inhibitor use

Diabetes






Answers:
a and c

b

d

c

c





References
1.
Campbell
KM

Yazigi
N

Ryckman
FC

Alonso
M

Tiao
G

Balistreri
WF

Atherton
H

Bucuvalas
JC


High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation
J Pediatr
2006
148
475
480

16647407


2.
Mention
K

Lahoche-Manucci
A

Bonnevalle
M

Pruvot
FR

Declerck
N

Foulard
M

Gottrand
F


Renal function outcome in pediatric liver transplant recipients
Pediatr Transplant
2005
9
201
207

15787794


3.
Berg
UB

Ericzon
BG

Nemeth
A


Renal function before and long after liver transplantation in children
Transplantation
2001
72
631
637

11544422


4.
Kalicinski
P

Szymczak
M

Smirska
E

Pawlowska
J

Teisseyre
M

Kaminski
A

Broniszczak
D

Lembas
A

Klimaszewski
J


Longitudinal study of renal function in pediatric liver transplant recipients
Ann Transplant
2005
10
53
58

16218034


5.
Kim
DY

Lim
C

Parasuraman
R

Raoufi
M

Yoshida
A

Arenas
J

Denny
J

Malinzak
L

Almarastani
M

Moonka
D

Brown
K

Sherbondy
M

Gordon
S

Abouljoud
M


Renal disease burden following liver transplantation
Transplant Proc
2006
38
3663
3665

17175361


6.
Boucek
MM

Waltz
DA

Edwards
LB

Taylor
DO

Keck
BM

Trulock
EP

Hertz
MI


Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart transplantation report–2006
J Heart Lung Transplant
2006
25
893
903

16890109


7.
Ross
M

Kouretas
P

Gamberg
P

Miller
J

Burge
M

Reitz
B

Robbins
R

Chin
C

Bernstein
D


Ten- and 20-year survivors of pediatric orthotopic heart transplantation
J Heart Lung Transplant
2006
25
261
270

16507417


8.
Smith
RR

Wray
J

Khaghani
A

Yacoub
M


Ten year survival after paediatric heart transplantation: a single centre experience
Eur J Cardiothorac Surg
2005
27
790
794

15848315


9.
Phan
V

West
LJ

Stephens
D

Hebert
D


Renal complications following heart transplantation in children: a single-center study
Am J Transplant
2003
3
214
218

12603215


10.
Sigfusson
G

Fricker
FJ

Bernstein
D

Addonizio
LJ

Baum
D

Hsu
DT

Chin
C

Miller
SA

Boyle
GJ

Miller
J

Lawrence
KS

Douglas
JF

Griffith
BP

Reitz
BA

Michler
RE

Rose
EA

Webber
SA


Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years
J Pediatr
1997
130
862
871

9202606


11.
Ishani
A

Erturk
S

Hertz
MI

Matas
AJ

Savik
K

Rosenberg
ME


Predictors of renal function following lung or heart–lung transplantation
Kidney Int
2002
61
2228
2234

12028464


12.
Canales
M

Youssef
P

Spong
R

Ishani
A

Savik
K

Hertz
M

Ibrahim
HN


Predictors of chronic kidney disease in long-term survivors of lung and heart–lung transplantation
Am J Transplant
2006
6
2157
2163

16827787


13.
Kunst
H

Thompson
D

Hodson
M


Hypertension as a marker for later development of end-stage renal failure after lung and heart–lung transplantation: a cohort study
J Heart Lung Transplant
2004
23
1182
1188

15477113


14.
Tarbell
NJ

Guinan
EC

Niemeyer
C

Mauch
P

Sallan
SE

Weinstein
HJ


Late onset of renal dysfunction in survivors of bone marrow transplantation
Int J Radiat Oncol Biol Phys
1988
15
99
104

2968967


15.
Cohen
EP

Lawton
CA

Moulder
JE


Bone marrow transplant nephropathy: radiation nephritis revisited
Nephron
1995
70
217
222

7566307


16.
Weiss
AS

Sandmaier
BM

Storer
B

Storb
R

McSweeney
PA

Parikh
CR


Chronic kidney disease following non-myeloablative hematopoietic cell transplantation
Am J Transplant
2006
6
89
94

16433761


17.
Hingorani
S

Guthrie
KA

Schoch
G

Weiss
NS

McDonald
GB


Chronic kidney disease in long-term survivors of hematopoietic cell transplant
Bone Marrow Transplant
2007
39
223
229

17290279


18.
Cohen
EP

Piering
WF

Kabler-Babbitt
C

Moulder
JE


End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD
Nephron
1998
79
408
412

9689155


19.
Thomas
SE

Hutchinson
RJ

DebRoy
M

Magee
JC


Successful renal transplantation following prior bone marrow transplantation in pediatric patients
Pediatr Transplant
2004
8
507
512

15367289


20.
Ojo
AO

Held
PJ

Port
FK

Wolfe
RA

Leichtman
AB

Young
EW

Arndorfer
J

Christensen
L

Merion
RM


Chronic renal failure after transplantation of a nonrenal organ
N Engl J Med
2003
349
931
940

12954741


21.
Chin
SE

Axelsen
RA

Crawford
DH

Endre
ZH

Lynch
SV

Balderson
GA

Strong
RW

Shepherd
RW

Burke
JR

Fleming
SJ


Glomerular abnormalities in children undergoing orthotopic liver transplantation
Pediatr Nephrol
1992
6
407
411

1457320


22.
Querfeld
U

Boechat
IM

Vargas
J

Hawkins
R

Berquist
B

Kangarloo
H

Busuttil
RW

Fine
RN


Renal ultrasound abnormalities in children with end-stage liver disease–reversal by liver transplantation
Pediatr Nephrol
1991
5
18
21

2025531


23.
Velidedeoglu
E

Bloom
RD

Crawford
MD

Desai
NM

Campos
L

Abt
PL

Markmann
JW

Mange
KC

Olthoff
KM

Shaked
A

Markmann
JF


Early kidney dysfunction post liver transplantation predicts late chronic kidney disease
Transplantation
2004
77
553
556

15084934


24.
Fisher
NC

Nightingale
PG

Gunson
BK

Lipkin
GW

Neuberger
JM


Chronic renal failure following liver transplantation: a retrospective analysis
Transplantation
1998
66
59
66

9679823


25.
Pillebout
E

Nochy
D

Hill
G

Conti
F

Antoine
C

Calmus
Y

Glotz
D


Renal histopathological lesions after orthotopic liver transplantation (OLT)
Am J Transplant
2005
5
1120
1129

15816895


26.
Gonwa
TA

Mai
ML

Melton
LB

Hays
SR

Goldstein
RM

Levy
MF

Klintmalm
GB


End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment
Transplantation
2001
72
1934
1939

11773892


27.
Atkinson
K

Biggs
JC

Hayes
J

Ralston
M

Dodds
AJ

Concannon
AJ

Naidoo
D


Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes
Br J Haematol
1983
54
59
67

6342655


28.
Myers
BD

Sibley
R

Newton
L

Tomlanovich
SJ

Boshkos
C

Stinson
E

Luetscher
JA

Whitney
DJ

Krasny
D

Coplon
NS

Perlroth
MG


The long-term course of cyclosporine-associated chronic nephropathy
Kidney Int
1988
33
590
600

3283402


29.
Myers
BD

Ross
J

Newton
L

Luetscher
J

Perlroth
M


Cyclosporine-associated chronic nephropathy
N Engl J Med
1984
311
699
705

6382005


30.
McDiarmid
SV


Renal function in pediatric liver transplant patients
Kidney Int Suppl
1996
53
S77
S84

8770996


31.
Wetering
J

Weimar
CH

Balk
AH

Roodnat
JI

Holweg
CT

Baan
CC

Domburg
RT

Weimar
W


The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation
Transplantation
2006
82
1744
1748

17198270


32.
Ferraris
JR

Duca
P

Prigoshin
N

Tambutti
ML

Boldrini
G

Cardoni
RL

D’Agostino
D


Mycophenolate mofetil and reduced doses of cyclosporine in pediatric liver transplantation with chronic renal dysfunction: changes in the immune responses
Pediatr Transplant
2004
8
454
459

15367280


33.
Laine
J

Krogerus
L

Fyhrquist
F

Jalanko
H

Ronnholm
K

Holmberg
C


Renal function and histopathologic changes in children after liver transplantation
J Pediatr
1994
125
863
869

7996357


34.
Vester
U

Kranz
B

Nadalin
S

Paul
A

Becker
J

Hoyer
PF


Sirolimus rescue of renal failure in children after combined liver-kidney transplantation
Pediatr Nephrol
2005
20
686
689

15723197


35.
Al Aly
Z

Abbas
S

Moore
E

Diallo
O

Hauptman
PJ

Bastani
B


The natural history of renal function following orthotopic heart transplant
Clin Transplant
2005
19
683
689

16146562


36.
Veillon
S

Caillard
S

Epailly
E

Eisenmann
B

Hannedouche
T

Moulin
B


Chronic renal failure after cardiac transplantation: predictive factors and influence on mortality-results of a monocenter study in 141 patients
Transplant Proc
2002
34
2819
2820

12431620


37.
Lee
CK

Christensen
LL

Magee
JC

Ojo
AO

Harmon
WE

Bridges
ND


Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study
J Heart Lung Transplant
2007
26
458
465

17449414


38.
Lindelow
B

Bergh
CH

Herlitz
H

Waagstein
F


Predictors and evolution of renal function during 9 years following heart transplantation
J Am Soc Nephrol
2000
11
951
957

10770975


39.
Esposito
C

Semeraro
L

Bellotti
N

Fasoli
G

Fornoni
A

Rampino
T

Klersy
C

Campana
C

Gavazzi
A

Vigano
M

Dal Canton
A


Risk factors for chronic renal dysfunction in cardiac allograft recipients
Nephron
2000
84
21
28

10644904


40.
Hendawy
A

Pouteil-Noble
C

Villar
E

Boissonnat
P

Sebbag
L


Chronic renal failure and end-stage renal disease are associated with a high rate of mortality after heart transplantation
Transplant Proc
2005
37
1352
1354

15848718


41.
Laine
J

Jalanko
H

Leijala
M

Sairanen
H

Holmberg
C


Kidney function in cyclosporine-treated pediatric heart transplant recipients
J Heart Lung Transplant
1997
16
1217
1224

9436133


42.
Hornung
TS

Goede
CG

O’Brien
C

Moghal
NE

Dark
JH

O’Sullivan
F


Renal function after pediatric cardiac transplantation: the effect of early cyclosporin dosage
Pediatrics
2001
107
1346
1350

11389255


43.
Rubel
JR

Milford
EL

McKay
DB

Jarcho
JA


Renal insufficiency and end-stage renal disease in the heart transplant population
J Heart Lung Transplant
2004
23
289
300

15019638


44.
Boyer
O

Bidois
J

Dechaux
M

Gubler
MC

Niaudet
P


Improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil
Transplantation
2005
79
1405
1410

15912111


45.
Asante-Korang
A

Boyle
GJ

Webber
SA

Miller
SA

Fricker
FJ


Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects
J Heart Lung Transplant
1996
15
415
422

8732602


46.
Parimon
T

Au
DH

Martin
PJ

Chien
JW


A risk score for mortality after allogeneic hematopoietic cell transplantation
Ann Intern Med
2006
144
407
414

16549853


47.
Moake
JL


Thrombotic microangiopathies
N Engl J Med
2002
347
589
600

12192020


48.
Antignac
C

Gubler
MC

Leverger
G

Broyer
M

Habib
R


Delayed renal failure with extensive mesangiolysis following bone marrow transplantation
Kidney Int
1989
35
1336
1344

2671466


49.
Lawton
CA

Cohen
EP

Murray
KJ

Derus
SW

Casper
JT

Drobyski
WR

Horowitz
MM

Moulder
JE


Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation
Bone Marrow Transplant
1997
20
1069
1074

9466280


50.
Pettitt
AR

Clark
RE


Thrombotic microangiopathy following bone marrow transplantation
Bone Marrow Transplant
1994
14
495
504

7858524


51.
Schriber
JR

Herzig
GP


Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
Semin Hematol
1997
34
126
133

9109214


52.
Zeigler
ZR

Rosenfeld
CS

Andrews
DF

Nemunaitis
J

Raymond
JM

Shadduck
RK

Kramer
RE

Gryn
JF

Rintels
PB

Besa
EC

George
JN


Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM)
Am J Hematol
1996
53
213
220

8948657


53.
Chappell
ME

Keeling
DM

Prentice
HG

Sweny
P


Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation
Bone Marrow Transplant
1988
3
339
347

2844348


54.
Sarkodee-Adoo
C

Sotirescu
D

Sensenbrenner
L

Rapoport
AP

Cottler-Fox
M

Tricot
G

Ruehle
K

Meisenberg
B


Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A
Transfusion
2003
43
78
84

12519434


55.
Uderzo
C

Fumagalli
M

Lorenzo
P

Busca
A

Vassallo
E

Bonanomi
S

Lanino
E

Dini
G

Varotto
S

Messina
C

Miniero
R

Valsecchi
MG

Balduzzi
A


Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation
Bone Marrow Transplant
2000
26
1005
1009

11100281


56.
Fuge
R

Bird
JM

Fraser
A

Hart
D

Hunt
L

Cornish
JM

Goulden
N

Oakhill
A

Pamphilon
DH

Steward
CG

Marks
DI


The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation
Br J Haematol
2001
113
58
64

11328282


57.
Hahn
T

Alam
AR

Lawrence
D

Ford
L

Baer
MR

Bambach
B

Bernstein
ZP

Czuczman
MS

Silva
J

Slack
JL

Wetzler
M

Becker
J

McCarthy
PL


Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion
Transplantation
2004
78
1515
1522

15599317


58.
Daly
AS

Hasegawa
WS

Lipton
JH

Messner
HA

Kiss
TL


Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver
Transfus Apher Sci
2002
27
3
12

12201469


59.
Uderzo
C

Bonanomi
S

Busca
A

Renoldi
M

Ferrari
P

Iacobelli
M

Morreale
G

Lanino
E

Annaloro
C

Volpe
AD

Alessandrino
P

Longoni
D

Locatelli
F

Sangalli
H

Rovelli
A


Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
Transplantation
2006
82
638
644

16969286


60.
Why
SK

Friedman
AL

Wei
LJ

Hong
R


Renal insufficiency after bone marrow transplantation in children
Bone Marrow Transplant
1991
7
383
388

2070148


61.
Lonnerholm
G

Carlson
K

Bratteby
LE

Backlund
L

Hagberg
H

Rikner
G

Smedmyr
B

Oberg
G

Simonsson
B


Renal function after autologous bone marrow transplantation
Bone Marrow Transplant
1991
8
129
134

1933054


62.
Kist-van Holthe
JE

Goedvolk
CA

Brand
R

Weel
MH

Bredius
RG

Oostayen
JA

Vossen
JM

Heijden
BJ


Prospective study of renal insufficiency after bone marrow transplantation
Pediatr Nephrol
2002
17
1032
1037

12478353


63.
Gronroos
MH

Bolme
P

Winiarski
J

Berg
UB


Long-term renal function following bone marrow transplantation
Bone Marrow Transplant
2007
39
717
723

17401393


64.
Berg
U

Bolme
P


Renal function in children following bone marrow transplantation
Transplant Proc
1989
21
3092
3094

2650432


65.
Levey
AS

Bosch
JP

Lewis
JB

Greene
T

Rogers
N

Roth
D


A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group
Ann Intern Med
1999
130
461
470

10075613


66.
Fliser
D

Franek
E

Joest
M

Block
S

Mutschler
E

Ritz
E


Renal function in the elderly: impact of hypertension and cardiac function
Kidney Int
1997
51
1196
1204

9083286


67.
Patzer
L

Ringelmann
F

Kentouche
K

Fuchs
D

Zintl
F

Brandis
M

Zimmerhackl
LB

Misselwitz
J


Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial
Bone Marrow Transplant
2001
27
319
327

11277181


68.
Kist-van Holthe
J

Zwet
J

Brand
R

Weel
M

Vossen
J

Heijden
A


Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT
Bone Marrow Transplantation
1998
22
559
564

9758343


69.
Frisk
P

Bratteby
LE

Carlson
K

Lonnerholm
G


Renal function after autologous bone marrow transplantation in children: a long-term prospective study
Bone Marrow Transplant
2002
29
129
136

11850707


70.
Rao
PS


Nephrotic syndrome in patients with peripheral blood stem cell transplant
Am J Kidney Dis
2005
45
780
785

15806483


71.
Brukamp
K

Doyle
AM

Bloom
RD

Bunin
N

Tomaszewski
JE

Cizman
B


Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease
Clin J Am Soc Nephrol
2006
1
685
694

17699273


72.
Chan
GS

Lam
MF

Au
WY

Tse
KC

Chan
TM

Lai
KN

Chan
KW


IgA nephropathy complicating graft-versus-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation
Histopathology
2004
45
648
651

15569061


73.
Oliveira
JS

Bahia
D

Franco
M

Balda
C

Stella
S

Kerbauy
J


Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal
Bone Marrow Transplant
1999
23
99
101

10037059


74.
Suehiro
T

Masutani
K

Yokoyama
M

Tokumoto
M

Tsuruya
K

Fukuda
K

Kanai
H

Katafuchi
R

Nagatoshi
Y

Hirakata
H


Diffuse proliferative glomerulonephritis after bone marrow transplantation
Clin Nephrol
2002
58
231
237

12356194


75.
Nouri-Majelan
N

Sanadgol
H

Ghafari
A

Rahimian
M

Najafi
F

Mortazavizadeh
M

Moghaddasi
S


Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation
Transplant Proc
2005
37
3213
3215

16213351


76.
Chien
YH

Lin
KH

Lee
TY

Lu
MY

Tsau
YK


Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease
J Formos Med Assoc
2000
99
503
506

10925558


77.
Reddy
P

Johnson
K

Uberti
JP

Reynolds
C

Silver
S

Ayash
L

Braun
TM

Ratanatharathorn
V


Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplant
2006
38
351
357

16862167


78.
Lubitz
SA

Pinney
S

Wisnivesky
JP

Gass
A

Baran
DA


Statin therapy associated with a reduced risk of chronic renal failure after cardiac transplantation
J Heart Lung Transplant
2007
26
264
272

17346629


79.
Dharnidharka
VR

Kwon
C

Stevens
G


Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis
Am J Kidney Dis
2002
40
221
226

12148093


80.
Al-Tonbary
YA

Hammad
AM

Zaghloul
HM

El-Sayed
HE

Abu-Hashem
E


Pretreatment cystatin C in children with malignancy: can it predict chemotherapy-induced glomerular filtration rate reduction during the induction phase
J Pediatr Hematol Oncol
2004
26
336
341

15167345


81.
Seronie-Vivien
S

Toullec
S

Malard
L

Thomas
F

Durrand
V

Chatelut
E


Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients
Med Oncol
2006
23
63
73

16645231


82.
Ross
EA

Wilkinson
A

Hawkins
RA

Danovitch
GM


The plasma creatinine concentration is not an accurate reflection of the glomerular filtration rate in stable renal transplant patients receiving cyclosporine
Am J Kidney Dis
1987
10
113
117

3300293


83.
Visvardis
G

Griveas
I

Zilidou
R

Papadopoulou
D

Mitsopoulos
E

Kyriklidou
P

Manou
E

Ginikopoulou
E

Meimaridou
D

Pavlitou
A

Sakellariou
G


Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate
Transplant Proc
2004
36
1757
1759

15350470


84.
Bokenkamp
A

Domanetzki
M

Zinck
R

Schumann
G

Byrd
D

Brodehl
J


Cystatin C–a new marker of glomerular filtration rate in children independent of age and height
Pediatrics
1998
101
875
881

9565418


85.
Filler
G

Lepage
N


Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula
Pediatr Nephrol
2003
18
981
985

12920638


86.
Cohen
EP


Radiation nephropathy after bone marrow transplantation
Kidney Int
2000
58
903
918

10916120


87.
Lopez Santi
RG

Valeff
EC

Duymovich
CR

Mazziotta
D

Mijailovsky
NE

Filippa
GC

Maltez
R

Hernandez
VA

Monroy
AG

Borzi
JG

Acheme
RA

Etchegoyen
MC


Effects of an angiotensin-converting enzyme inhibitor (ramipril) on inflammatory markers in secondary prevention patients: RAICES Study
Coron Artery Dis
2005
16
423
429

16205450


88.
Dagenais
NJ

Jamali
F


Protective effects of angiotensin II interruption: evidence for antiinflammatory actions
Pharmacotherapy
2005
25
1213
1229

16164395


89.
Lin
J

Valeri
AM

Markowitz
GS

D’Agati
VD

Cohen
DJ

Radhakrishnan
J


Angiotensin converting enzyme inhibition in chronic allograft nephropathy
Transplantation
2002
73
783
788

11907428


90.
Hetzel
GR

Hermsen
D

Hohlfeld
T

Rettich
A

Ozcan
F

Fussholler
A

Grabensee
B

Plum
J


Effects of candesartan and perindopril on renal function, TGF-beta1 plasma levels and excretion of prostaglandins in stable renal allograft recipients
Clin Nephrol
2002
57
296
302

12005246


91.
Maschio
G

Alberti
D

Janin
G

Locatelli
F

Mann
JF

Motolese
M

Ponticelli
C

Ritz
E

Zucchelli
P


Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group
N Engl J Med
1996
334
939
945

8596594


92.
Sica
DA

Gehr
TW

Fernandez
A


Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease
Drug Saf
2000
22
350
360

10830252


93.
Brozena
SC

Johnson
MR

Ventura
H

Hobbs
R

Miller
L

Olivari
MT

Clemson
B

Bourge
R

Quigg
R

Mills
RM

Naftel
D


Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail
J Am Coll Cardiol
1996
27
1707
1712

8636558


94.
Elliott
WJ

Murphy
MB

Karp
R


Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic
J Heart Lung Transplant
1991
10
373
379

1854764


95.
Snell
GI

Levvey
B

Chin
W

Richardson
M

Kotsimbos
T

Whitford
HM

Williams
TJ


Sirolimus (rapamycin) allows renal recovery in lung and heart transplant recipients with chronic renal impairment
J Heart Lung Transplant
2001
20
163
164

11250247


96.
Venuta
F

Giacomo
T

Rendina
EA

Quattrucci
S

Mercadante
E

Cimino
G

Ibrahim
M

Diso
D

Bachetoni
A

Coloni
GF


Recovery of chronic renal impairment with sirolimus after lung transplantation
Ann Thorac Surg
2004
78
1940
1943

15561004


97.
Butcher
JA

Hariharan
S

Adams
MB

Johnson
CP

Roza
AM

Cohen
EP


Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression
Clin Transplant
1999
13
330
335

10485375


98.
Hamawi
K

Magalhaes-Silverman
M

Bertolatus
JA


Outcomes of renal transplantation following bone marrow transplantation
Am J Transplant
2003
3
301
305

12614285


99.
Kuo
PC

Luikart
H

Busse-Henry
S

Hunt
SA

Valantine
HA

Stinson
EB

Oyer
PE

Scandling
JD

Alfrey
EJ

Dafoe
DC


Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients
Clin Transplant
1995
9
92
97

7599409


100.
Frimat
L

Villemot
JP

Cormier
L

Cao-Huu
T

Renoult
E

Hestin
D

Dopff
C

Mattei
S

Hubert
J

Kessler
M


Treatment of end-stage renal failure after heart transplantation
Nephrol Dial Transplant
1998
13
2905
2908

9829499


101.
Molmenti
EP

Jain
AB

Shapiro
R

Scantlebury
V

Lee
R

Totsuka
E

Flohr
J

Rakela
J

Fung
JJ


Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection
Transplantation
2001
71
267
271

11213072


102.
National Kidney Foundation

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
Am J Kidney Dis
2002
39
Suppl 1
S1
S266

11904577





